• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Diagnostics

First OTC molecular test for COVID-19 gains FDA nod

March 5, 2021 By Nancy Crotti Leave a Comment

The FDA today issued its first emergency use authorization for a molecular COVID-19 diagnostic test for at-home use without a prescription. The Cue Health COVID-19 Test for Home and Over The Counter (OTC) use is a molecular nucleic acid amplification test designed to detect genetic material from the SARS-CoV-2 virus in the nostrils. The authorized […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: coronavirus, COVID-19, Cue Health, FDA

Abbott wins EUA for COVID-19, flu, RSV combo assay

March 5, 2021 By Sean Whooley Leave a Comment

Abbott (NYSE:ABT) announced today that it received FDA emergency use authorization (EUA) for its Alinity m Resp-4-Plex molecular assay. The laboratory PCR diagnostic is designed to detect and differentiate between SARS-CoV-2 (the virus causing COVID-19), influenza A, influenza B and respiratory syncytial virus (RSV) in one test. It already has CE Mark approval and is […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: Abbott, coronavirus, COVID-19, FDA

Hillrom execs change their minds on BardyDx acquisition

March 3, 2021 By Chris Newmarker Leave a Comment

Hillrom (NYSE:HRC) says closing conditions have not been met when it comes to the company’s previously planned $375 million acquisition of Bardy Diagnostics and its Carnation Ambulatory Monitor, or CAM patch. In response, BardyDx has sued Hillrom in the Delaware Court of Chancery, asking the court to order the merger to proceed because Hillrom’s argument […]

Filed Under: Business/Financial News, Cardiovascular, Diagnostics, Digital Health, Featured, Mergers & Acquisitions Tagged With: Bardy Diagnostics, Boston Scientific, Hillrom, iRhythm Technologies Inc., Preventice

Abbott COVID-19 serology test gains EUA

March 3, 2021 By Sean Whooley Leave a Comment

Abbott (NYSE:ABT) this week received FDA emergency use authorization (EUA) for its AdviseDx SARS-CoV-2 IgG II diagnostic — providing another tool to detect people’s adaptive immune response to COVID-19. The serology test from Abbott Park, Ill.-based Abbott is indicated for the qualitative and semi-quantitative detection of IgG antibodies to SARS-CoV-2 — the virus causing COVID-19 […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: Abbott, coronavirus, COVID-19, FDA

Boston Scientific completes Preventice buy, divests BTG Pharmaceutical business

March 2, 2021 By Sean Whooley Leave a Comment

Boston Scientific (NYSE:BSX) announced that it completed its acquisition of Preventice Solutions that could be worth up to $1.225 billion. The transaction includes a cash payment of $925 million upfront with up to an additional $300 million in potential commercial milestone payments available. Accounting for the company’s approximately 22% equity stake in Preventice prior to the […]

Filed Under: Business/Financial News, Cardiovascular, Diagnostics, Featured, Health Technology, Mergers & Acquisitions, Pharmaceutical, Software / IT Tagged With: Boston Scientific, BTG, Preventice, SERB

Quidel wins FDA nod for at-home antigen test

March 1, 2021 By Nancy Crotti Leave a Comment

The FDA issued an emergency use authorization today for the Quidel Corp. (NSDW:QDEL) QuickVue At-Home COVID-19 test, another antigen test to rapidly collect and test samples at home, without the need to send a sample to a laboratory for analysis. The QuickVue At-Home COVID-19 test is authorized for prescription home use with self-collected nasal swab […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Abbott, antigen test, CareEvolution, coronavirus, COVID-19, Ellume, National Institutes of Health (NIH), Quidel Corp.

Eurofins launches direct-to-consumer home COVID-19 PCR test

March 1, 2021 By Sean Whooley Leave a Comment

Eurofins (Paris:ERF.PA) announced today that it received FDA emergency use authorization (EUA) for its direct-to-consumer COVID-19 test. Luxembourg-based Eurofins’ EmpowerDX at-home COVID-19 nasal PCR test collection kit can be sold directly to consumers without a prescription to aid in testing for SARS-CoV-2, the virus causing COVID-19, according to a news release. Currently, the kit is available […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance

Hologic acquires molecular diagnostic company for $159M

March 1, 2021 By Danielle Kirsh Leave a Comment

Hologic today announced that it acquired molecular diagnostic company Diagenode for $159 million. Through the deal, Hologic will pay $159 million, subject to working capital and other customary closing adjustments. European Diagenode develops molecular diagnostic assays and epigenetic products. It has more than 30 real-time PCR tests that are CE-marked to detect bacteria, parasites and […]

Filed Under: Diagnostics, Featured, Genomics/Molecular Diagnostics, Mergers & Acquisitions Tagged With: Diagenode, Hologic

The top 7 medtech CEO quotes on COVID-19, one year later

February 26, 2021 By Danielle Kirsh Leave a Comment

The latest earnings season has provided insights into the future of medtech in the COVID-19 landscape and what certain sectors are seeing as vaccines start to roll out. Since the start of the pandemic, 113.1 million COVID-19 cases have been reported worldwide, according to Johns Hopkins University School of Medicine. The U.S. leads the world […]

Filed Under: Business/Financial News, Cardiovascular, Dental, Diabetes, Diagnostics, Featured, Hospital Care, Imaging, Implants, Neuromodulation/Neurostimulation, Orthopedics Tagged With: Baxter, coronavirus, COVID-19, Henry Schein, Integra LifeSciences, Medtronic, Nevro Corp., Owens & Minor, Zimmer Biomet

Forest Devices touts study of stroke detection tech

February 26, 2021 By Sean Whooley Leave a Comment

Forest Devices this week touted study results for its AlphaStroke technology for identifying patients with large vessel occlusive (LVO) strokes. Pittsburgh-based Forest Devices, one of MassDevice’s 2020 medical device startups you need to know, designed the AlphaStroke platform to detect stroke and LVO, offering first responders the ability to use the system to triage patients […]

Filed Under: Clinical Trials, Diagnostics, Featured, Hospital Care, Patient Monitoring Tagged With: Forest Devices

iRhythm’s revenue jumps 33% in Q4

February 26, 2021 By Chris Newmarker Leave a Comment

iRhythm Technologies (NASDAQ: IRTC) reported mixed Q4 results but predicted strong sales growth in 2021. The San Francisco–based company — maker of the Zio ambulatory cardiac monitoring patch — reported a loss of –$9.7 million, or –33¢ per share, on sales of $78.8 million for the three months ended Dec. 31, 2020, nearly halving its […]

Filed Under: Business/Financial News, Cardiovascular, Diagnostics, Digital Health, Featured, Wall Street Beat Tagged With: iRhythm Technologies Inc.

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 153
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS